should ocrelizumab & cladribine be treated in the same way as alemtuzumab in terms of covid-19 risk?
Published 4 years ago • 1.3K plays • Length 58:22Download video MP4
Download video MP3
Similar videos
-
57:37
prof gavin giovannoni: managing ms remotely during the covid-19 pandemic
-
55:48
webinar: the impact of covid-19 on multiple sclerosis management
-
1:35:39
multiple sclerosis in the covid-19 era: what you need to know | a webinar for patients
-
0:12
why neurologists are key in covid-19 care
-
48:20
use of steroids and covid-19 risk; is there a need to modify their use?
-
1:06:28
update of covid-19 and ms – morbidity and mortality figures | ms academy
-
7:39
considerations for using oral cladribine in ms
-
7:39
considerations for using oral cladribine in ms
-
4:04
augusto miravalle, md: cladribine paves the way as new ms treatment
-
1:00:25
understanding the covid-19 impact on ms in people of color
-
1:09:42
vaccination – will our patients be able to respond to a coronavirus vaccine? | ms academy
-
3:53
neurobytes: what neurologists should know about covid-19 - american academy of neurology
-
1:33:53
ms education: multiple sclerosis and covid-19 | ohio state medical center
-
1:14:47
formalising remote management of multiple sclerosis | ms academy #mscovid19
-
1:08:27
ask the experts: #mscovid19 mind health session for msers
-
4:28
oral cladribine therapy for ms
-
42:22
ahsct for highly active and rapidly evolving severe ms during the covid-19 pandemic
-
4:05
multiple sclerosis vlog: covid-19, ocrevus and your risk [3/2020]
-
50:23
pregnancy – what should we advise our patients during the covid-19 pandemic? | ms academy